The U.S. Food and Drug Administration has approved Xenpozyme (olipudase alfa) for pediatric and adult patients with acid sphingomyelinase deficiency (ASMD), a rare genetic disease.
You may also be interested in:
Researchers are joining forces with the food and health industries to tighten controls and improve nutrition for infants and children.This article was originally published on [...]
Toddlers whose moms were exposed to higher levels of air pollution during mid- to late-pregnancy tend to score lower on measures of cognition, motor coordination [...]
When visiting friends or family who have both houseplants and young children, I’ve been compared to “Aunt Bonnie” from the Geico commercial “Aunt Infestation.”This article [...]